Skip to main content

Research Repository

Advanced Search

All Outputs (9)

Cool facial airflow hastens exertion recovery in chronic breathlessness: randomised crossover trial of different fan airflow speeds (2025)
Journal Article
Burrell, T., Simpson, A., Ramsenthaler, C., Crooks, M. G., Johnson, M. J., & Swan, F. (in press). Cool facial airflow hastens exertion recovery in chronic breathlessness: randomised crossover trial of different fan airflow speeds. BMJ Supportive & Palliative Care, https://doi.org/10.1136/spcare-2024-005103

Objectives Facial airflow from a hand-held fan (fan) hastens recovery from exertional breathlessness. We aimed to determine the effect of different airflow speeds on recovery from exertional breathlessness in patients with chronic breathlessness.
Me... Read More about Cool facial airflow hastens exertion recovery in chronic breathlessness: randomised crossover trial of different fan airflow speeds.

Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Protocol for a European Delphi study (2025)
Journal Article
Deneche, I., Couffignal, C., Mohammed, N. S., Højen, A. A., Font, C., Konstantinides, S., Kruip, M., Maiorana, L., Szmit, S., Abbel, D., Bertoletti, L., Cannegieter, S., Edwards, A., Edwards, M., Gava, A., Gussekloo, J., Johnson, M. J., Kumar, R., Langendoen, J., Lifford, K., …Mahé, I. (2025). Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Protocol for a European Delphi study. Thrombosis Research, 19, Article 100209. https://doi.org/10.1016/j.tru.2025.100209

Introduction: To develop a European shared decision support tool (SDST), a Delphi process will be used to reach consensus about aspects relating to the continuation or deprescribing of antithrombotic therapy (ATT) in cancer patients at the end of lif... Read More about Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Protocol for a European Delphi study.

Socioeconomic status and older adult's experiences of weight loss: a qualitative secondary analysis (2025)
Journal Article
Bullock, A., Newton-Clarke, A., Johnson, M. J., Murtagh, F. E., & Nwulu, U. (2025). Socioeconomic status and older adult's experiences of weight loss: a qualitative secondary analysis. PLoS ONE, 20(4), Article e0321313. https://doi.org/10.1371/journal.pone.0321313

Objectives Unintentional weight loss in older adults is common, with 15–20% of those aged >65 having clinically significant weight loss, associated with increased mortality and morbidity. People with socioeconomic disadvantage are more likely to be o... Read More about Socioeconomic status and older adult's experiences of weight loss: a qualitative secondary analysis.

Complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): a feasibility, wait-list design randomised controlled trial (2025)
Journal Article
Crooks, M. G., Wright, C., Hart, S., Allgar, V., English, A., Swan, F., Dyson, J., Richardson, G., Twiddy, M., Cohen, J., Simpson, A., Huang, C., Sykes, D. L., & Johnson, M. (2025). Complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): a feasibility, wait-list design randomised controlled trial. BMJ Open Respiratory Research, 12(1), Article e002327. https://doi.org/10.1136/bmjresp-2024-002327

Introduction Breathlessness is common and impairs the quality of life of people with idiopathic pulmonary fibrosis (IPF) and non-IPF fibrotic interstitial lung diseases (ILD). We report the findings of a multicentre, fast-track (wait-list), mixed-met... Read More about Complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): a feasibility, wait-list design randomised controlled trial.

BREATHLEssness in INDIA (BREATHE-INDIA): realist review to develop explanatory programme theory about breathlessness self-management in India (2025)
Journal Article
Clark, J., Salins, N., Sherigar, M., Williams, S., Pearson, M., Rao, S. R., Spathis, A., Bhat, R., Currow, D. C., Fraser, K., Simha, S., & Johnson, M. J. (2025). BREATHLEssness in INDIA (BREATHE-INDIA): realist review to develop explanatory programme theory about breathlessness self-management in India. NPJ Primary Care Respiratory Medicine, 35(1), Article 13. https://doi.org/10.1038/s41533-025-00420-2

Breathlessness is highly prevalent in low and middle-income countries (LMICs). Low-cost, non-drug, breathlessness self-management interventions are effective in high-income countries. However, health beliefs influence acceptability and have not been... Read More about BREATHLEssness in INDIA (BREATHE-INDIA): realist review to develop explanatory programme theory about breathlessness self-management in India.

Harms of Morphine for Chronic Breathlessness in Relation to Dose, Duration and Titration Phase (2025)
Journal Article
Ekström, M., Alameri, F., Chang, S., Ferreira, D., Johnson, M. J., & Currow, D. C. (in press). Harms of Morphine for Chronic Breathlessness in Relation to Dose, Duration and Titration Phase. Journal of pain and symptom management, https://doi.org/10.1016/j.jpainsymman.2025.02.020

Context: Morphine to treat severe chronic breathlessness might increase adverse events (AEs). Objectives: We aimed to evaluate the risk of AEs in relation to dose, duration and titration phase of regular, low-dose sustained-release (SR) oral morphine... Read More about Harms of Morphine for Chronic Breathlessness in Relation to Dose, Duration and Titration Phase.

ERS guideline recommendation on airflow for breathlessness: the pitfalls of applying GRADE evidence ratings to complex non-pharmacological interventions (2025)
Journal Article
Luckett, T., Swan, F., Clark, J., Roberts, M., Pearson, M., Hutchinson, A., Currow, D., Kochovska, S., Crooks, M., Smith, T., & Johnson, M. (2025). ERS guideline recommendation on airflow for breathlessness: the pitfalls of applying GRADE evidence ratings to complex non-pharmacological interventions. European respiratory journal, 65(2), Article 2402244. https://doi.org/10.1183/13993003.02244-2024

"I'm living in a 'no' world now…"- A qualitative study of the widespread impact of living with chronic breathlessness, and experiences of identification and assessment of this symptom in an older, frail community-based population (2025)
Journal Article
Elliott-Button, H., Johnson, M. J., Hutchinson, A., Currow, D. C., & Clark, J. (2025). "I'm living in a 'no' world now…"- A qualitative study of the widespread impact of living with chronic breathlessness, and experiences of identification and assessment of this symptom in an older, frail community-based population. NPJ Primary Care Respiratory Medicine, 35(1), Article 5. https://doi.org/10.1038/s41533-024-00409-3

Chronic breathlessness is a debilitating symptom with detrimental impact on individuals and carers. However, little is known about the experiences of community-dwelling, frail, older adults living with chronic breathlessness. To explore, (i) the psyc... Read More about "I'm living in a 'no' world now…"- A qualitative study of the widespread impact of living with chronic breathlessness, and experiences of identification and assessment of this symptom in an older, frail community-based population.

Delirium prevention in hospices: Opportunities and limitations – A focused ethnography (2025)
Journal Article
Featherstone, I., Johnson, M. J., Sheldon, T., Kelley, R., Hawkins, R., Bravington, A., Callin, S., Dixon, R., Obita, G., & Siddiqi, N. (2025). Delirium prevention in hospices: Opportunities and limitations – A focused ethnography. Palliative medicine, 39(3), 391-400. https://doi.org/10.1177/02692163241310762

Background: Delirium is common and distressing for hospice in-patients. Hospital-based research shows delirium may be prevented by targeting its risk factors. Many preventative strategies address patients’ fundamental care needs. However, there is li... Read More about Delirium prevention in hospices: Opportunities and limitations – A focused ethnography.